Literature DB >> 6943439

Muscle phosphofructokinase deficiency: abnormal polysaccharide in a case of late-onset myopathy.

A P Hays, M Hallett, J Delfs, J Morris, A Sotrel, M M Shevchuk, S DiMauro.   

Abstract

A 61-year-old woman with muscle phosphofructokinase (PFK) deficiency had mild limb weakness all her life but no cramps or myoglobinuria. For 5 years the limb weakness progressed. In muscle, PFK activity was 1% of normal and glycogen concentration was elevated (2.13%). By light microscopy, a minor component of the accumulated glycogen appeared as PAS-positive, diastase-resistant inclusions in 10% of muscle fibers. The inclusions had a filamentous fine structure that resembled the abnormal long-chain glycogen of brancher enzyme deficiency. Iodine absorption spectra of both the inclusions and a diastase-resistant fraction of isolated glycogen resembled amylopectin. The abnormal polysaccharide in PFK deficiency may be related to greatly elevated concentration of muscle glucose-6-phosphate, an activator of the chain-elongating enzyme glycogen synthase.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6943439     DOI: 10.1212/wnl.31.9.1077

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

Review 1.  Lafora disease, seizures and sugars.

Authors:  D M Andrade; J Turnbull; B A Minassian
Journal:  Acta Myol       Date:  2007-07

Review 2.  Update on polyglucosan storage diseases.

Authors:  Giovanna Cenacchi; V Papa; R Costa; V Pegoraro; R Marozzo; M Fanin; C Angelini
Journal:  Virchows Arch       Date:  2019-07-30       Impact factor: 4.064

3.  Late-onset polyglucosan body myopathy in five patients with a homozygous mutation in GYG1.

Authors:  H Orhan Akman; Yavuz Aykit; Ozge Ceren Amuk; Edoardo Malfatti; Norma B Romero; Maria Antonietta Maioli; Rachele Piras; Salvatore DiMauro; Gianni Marrosu
Journal:  Neuromuscul Disord       Date:  2015-11-10       Impact factor: 4.296

4.  Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative Diseases.

Authors:  Mitchell A Sullivan; Silvia Nitschke; Evan P Skwara; Peixiang Wang; Xiaochu Zhao; Xiao S Pan; Erin E Chown; Travis Wang; Ami M Perri; Jennifer P Y Lee; Francisco Vilaplana; Berge A Minassian; Felix Nitschke
Journal:  Cell Rep       Date:  2019-04-30       Impact factor: 9.423

5.  Characterization of the enzymatic defect in late-onset muscle phosphofructokinase deficiency. New subtype of glycogen storage disease type VII.

Authors:  S Vora; S DiMauro; D Spear; D Harker; M J Danon
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

Review 6.  Endomyocardial biopsy in the evaluation of conditions leading to cardiac transplantation and in the evaluation of cardiac allograft rejection.

Authors:  H A McAllister
Journal:  Tex Heart Inst J       Date:  1995

7.  A histochemical and electron microscopic study of skeletal muscle in an adult case of Chédiak-Higashi syndrome.

Authors:  M Uchino; E Uyama; T Hirano; T Nakamura; T Fukushima; M Ando
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

8.  Muscle phosphofructokinase deficiency. Biochemical and immunological studies of phosphofructokinase isozymes in muscle culture.

Authors:  M Davidson; A F Miranda; A N Bender; S DiMauro; S Vora
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

9.  Myopathies due to enzyme deficiencies.

Authors:  F Cornelio; S Di Donato
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

10.  Heterogeneity of the molecular lesions in inherited phosphofructokinase deficiency.

Authors:  S Vora; M Davidson; C Seaman; A F Miranda; N A Noble; K R Tanaka; E P Frenkel; S Dimauro
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.